For those keeping an eye on Cardinal Health, it’s worth delving into what the market might be saying about the stock.
Recent Performance
Cardinal Health recently closed at $185.28. Over the past year, it delivered a 27.2% return. If we look back even further, returns were impressive: 129.5% over three years and a staggering 270.6% over five years. However, the stock has faced recent declines, dropping 3.9% in the last week, 12.9% in the last month, and 9.9% year-to-date.
Recent news has spotlighted Cardinal Health’s significant role in the U.S. healthcare landscape. As a key distributor, its resilience amid changing industry dynamics is of great interest to investors. Many are reevaluating risks in the healthcare sector, keeping Cardinal Health under scrutiny.
Valuation Insights
Simply Wall St has assigned Cardinal Health a value score of 3 out of 6. A good way to assess its value is through different methods.
Discounted Cash Flow (DCF) Analysis
The DCF model looks at the cash a company is expected to generate in the future and brings those cash flows back to today’s value. For Cardinal Health, the latest twelve months’ free cash flow sits at about $4.40 billion. Analysts project this will grow to roughly $3.01 billion in 2026, $3.39 billion in 2027, and $4.28 billion in 2030. After adjusting for risk and the time value of money, the model estimates an intrinsic value of around $466.19 per share. This suggests the stock might currently be undervalued by about 60.3%.
Price-to-Earnings Ratio (P/E)
When evaluating a profitable company, the P/E ratio can reveal how much investors are willing to pay for each dollar of earnings. Cardinal Health has a current P/E of 27.91, which is above the healthcare industry average of 22.13.
Simply Wall St calculates a fair P/E ratio of about 27.09 for Cardinal Health. Given its current P/E, the stock appears fairly valued based on this method.
Gathering Perspectives
Investing insights can vary significantly. One investor might see potential for growth in Cardinal Health’s pharmaceutical and specialty distribution branches, estimating a fair value closer to $275. Another might focus on external risks, like regulatory changes, leading them to estimate a value of around $200.
This divergence in perspectives underscores the importance of context. Recently, a social media trend has emerged where investors share their insights on healthcare stocks, driving discussions on valuations and growth potential.
Conclusion
Cardinal Health remains a focal point in the investment community, particularly due to its role in the healthcare field and its impressive historical returns. The contrasting estimates of its fair value highlight the varied opinions in the market. As the healthcare landscape evolves, keeping track of these valuations and the narratives that shape them will be crucial for investors. For detailed data on Cardinal Health, you can check out Simply Wall St for more insights.
